Biotech · Private company
BPGbio
Track this companyFree. Adds BPGbio to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- API 31510Phase 2 · Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- API 31510 1.5% Topical CreamPhase 2 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- API 31510 3% Topical CreamPhase 2 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BPM31510Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- BPM31510 Nanosuspension InjectionPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RadiationPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Temozolomide (TMZ)Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin K1Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- BP31510 in combination with chemotherapyPhase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- BP31510 monotherapyPhase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 10 μg/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 20 μg/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 40 μg/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 5 μg/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 60 ug/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Compound 31543 Calcitriol 80 μg/mLPhase 1 · Chemotherapy-Induced AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Sterile Compound C31510 for InjectionPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 22, 2022ClinicalTrials.gov NCT04752813 · fetched Nov 12, 2026
- AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)RECRUITING · started Apr 22, 2021ClinicalTrials.gov NCT04807868 · fetched Nov 12, 2026
- Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With GlioblastomaACTIVE_NOT_RECRUITING · started Mar 1, 2021ClinicalTrials.gov NCT07674095 · fetched Nov 12, 2026
- BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer PatientsPHASE2 · COMPLETED · started Jul 6, 2016ClinicalTrials.gov NCT02650804 · fetched Nov 12, 2026
- BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid TumorsPHASE1 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01957735 · fetched Nov 12, 2026
- Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced AlopeciaPHASE1 · COMPLETED · started Sep 17, 2012ClinicalTrials.gov NCT01588522 · fetched Nov 12, 2026
- Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid TumorsPHASE1 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT01251562 · fetched Nov 12, 2026
- An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)PHASE1_PHASE2 · COMPLETED · started Jun 1, 2008ClinicalTrials.gov NCT00652080 · fetched Nov 12, 2026
- Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell CarcinomaPHASE1_PHASE2 · COMPLETED · started Mar 1, 2008ClinicalTrials.gov NCT00604890 · fetched Nov 12, 2026